The Good GP

THT Productions
THT Productions
  • 4.4 (9)
  • Medicine
  • Biweekly

The Good GP, the education podcast for busy GPs; brought to you by Dr Tim Koh, Dr Krystyna DeLange and Dr Sean Stevens. The Good GP is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Disclaimer: The Good GP podcasts are for informational purposes only and do not constitute medical advice. Always seek the advice of a specialist GP or other qualified health provider with any questions you may have regarding a medical condition.

  1. 6d ago

    Bradycardia diagnosis and general management

    In this episode of The Good GP, host Dr Kristiana Pederick welcomes Dr Justin Ng, a specialist cardiologist and electrophysiologist specialising in the diagnosis and management of arrhythmias. They discuss common presentations of bradycardia and how to distinguish between physiological and pathological low heart rates. Dr Justin highlights red flags in the presentation, investigation, and general management of bradyarrhythmia, as well as the uses and limitations of wearable tracking devices, such as smartwatches. They explore typical presentations of bradycardia, including syncope, near-syncope, reduced exercise tolerance, and cognitive decline in older adults. Dr Justin emphasises the importance of clinical context when distinguishing between physiological and pathological bradycardia, taking into account the patient's age, fitness level, symptoms, and the circumstances in which a low heart rate is identified. They also discuss management principles, including reserving pacemaker implantation for symptomatic or irreversible cases. The importance of taking a thorough patient history and correlating symptoms with documented bradycardia is emphasised to help determine the urgency of management and guide further investigations. The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  2. Oct 19

    Alzheimer's Disease biomarker testing

    In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care. Dr Steph Daly outlines that the test shows high positive and negative predictive value for Alzheimer’s pathology when used in the appropriate, symptomatic patient group, typically those over 55 presenting with clear cognitive or memory symptoms. Discussing the practical process for GPs to request the test, expected costs, and considerations for both urban and rural settings. They emphasise the need for pre-test counselling, careful patient selection, and the importance of structured clinical assessment to ensure meaningful use of the test. The application of this biomarker in asymptomatic individuals is not recommended at present, due to limited clinical utility and potential psychological harm. Listeners are encouraged to approach the test thoughtfully, seek additional education, and use it initially in patients where clinical suspicion of Alzheimer’s disease is already high. Links & Resources: Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment study: https://jamanetwork.com/journals/jama/article-abstract/2851720The Nun Study: Insights from 30 years of aging and dementia research: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14626Link to webinar and information on biomarker study currently being carried out in Australia: https://www.australiandementianetwork.org.au/improved-extended-study-blood-based-biomarkers-for-alzheimers-disease-in-primary-care-project/ The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  3. Oct 12

    Naltrexone in alcohol use disorder

    In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD). Dr Leitinger explains how naltrexone, an opioid antagonist, disrupts the endorphin-mediated reward of alcohol consumption, helping patients gradually reduce intake and unlearn habitual drinking behaviours. He highlights that naltrexone can be prescribed while patients are still drinking, not only during abstinence, and discusses flexible prescribing methods including daily dosing and the “Sinclair Method” of targeted dosing prior to drinking. Important considerations covered include contraindications such as concurrent opioid use and the approach to temporary cessation if opioid analgesia is needed. Dr Leitinger reassures that naltrexone is generally safe in patients with liver disease and recommends baseline and follow-up LFTs, though testing should not be a barrier to therapy. A case study illustrates practical patient outcomes, expectations, and follow-up. Strategies for supporting patients through lapses and individualising success measures are discussed, as well as where naltrexone fits alongside other first-line options like acamprosate. The value of harm reduction and ongoing patient support in primary care is emphasised. Link & Resources: AJGP article on naltrexone in alcohol use disorder: https://www1.racgp.org.au/ajgp/2026/january-february/naltrexoneCommunity Access to Pharmacotherapy for Alcohol (CAPA) EOI Form: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=xMYIFZVfdU-KZ5mS34Mn6CJfQHBGKCREk2C2wuYgdyNUM0IzSDc4WTVXMkNGT1VXWkYxMlNGQ0FIVy4u&origin=QRCodeA 2-step reduction in WHO alcohol risk drinking levels (rather than abstinence) for harm reduction: https://pmc.ncbi.nlm.nih.gov/articles/PMC12739655/ Stronger evidence for the effectiveness of naltrexone: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2727384 The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  4. Oct 5

    Antidepressant during pregnancy: Pharmacoepidemiologist’s perspective

    In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database. Dr Martin explains the definitions used for trimesters and miscarriage, and highlights the understanding confounding by indication; how underlying depression, rather than the use of antidepressants, may skew observed associations in raw data. After adjusting for confounding factors, her research found only a modest increase in miscarriage risk for women using antidepressants in the first trimester, with the absolute risk rising slightly from 13.1% to 13.6%. She further outlines the difference in risk between women who were already taking antidepressants when becoming pregnant and those who started during the first trimester. The findings suggest no increased miscarriage risk for continuing users, while those newly starting medication may show a slight increase, potentially due to residual confounding or early pregnancy detection bias. Dr Martin encourages GPs to communicate absolute risk clearly and to consider each patient’s context when discussing antidepressant use in pregnancy. Link & Resources: https://bjgp.org/content/75/761/e843 The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  5. Sep 28

    Antidepressant during pregnancy: Psychiatrist’s perspective

    In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations. Covering key assessment considerations, such as the severity of illness, history of hormonal sensitivity, trauma, and family psychiatric history. Dr Feutrill stresses the need to treat symptoms to remission rather than opting for subtherapeutic dosing, highlighting the low absolute risk of congenital malformations from antidepressant medications, especially compared to other modifiable risk factors. Sertraline is identified as the antidepressant with the most robust safety data for pregnancy. Examining neonatal adaptation syndrome and outlines current understanding regarding dose adjustments during pregnancy. Guidance is provided on managing abrupt discontinuation and when GP referral to psychiatry is appropriate. Dr Feutrill also draws attention to the growing recognition of hormonal sensitivity’s impact on mental health and encourages GPs to consider hormonal and neurobiological factors in their assessment and management. Link & Resources: Mothersafe NSW - https://www.seslhd.health.nsw.gov.au/royal-hospital-for-women/services-clinics/directory/mothersafeTGA - Obstetric drug information services - https://www.tga.gov.au/resources/health-professional-information-and-resources/australian-categorisation-system-prescribing-medicines-pregnancy/prescribing-medicines-pregnancy-database/obstetric-drug-information-servicesPerinatal Mental Health Guidelines - https://www.cope.org.au/uploads/images/Health-professionals/COPE_2023_Perinatal_Mental_Health_Practice_Guideline.pdf The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  6. Sep 21

    Fowl play: Bird flu and whooping cough update?

    In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis. They review the current status of H5N1 in Australia, where the virus has been detected in wild birds but no human cases have been reported. Dr Effler highlights the very low risk of transmission to the general public, based on international experience, and outlines which groups may be at relatively higher risk. He provides practical advice for GPs on risk assessment, testing, and when to involve public health units, as well as the importance of not causing unnecessary alarm. They also addressed the recent increase in pertussis cases in Western Australia. Dr Effler discusses the contribution of natural epidemic cycles and the importance of improving pertussis vaccination rates, especially for pregnant women, to protect infants. Links & Resources: Australian Centre for Disease Control - https://www.cdc.gov.au/diseases/bird-flu-avian-influenzaLight for Riley Foundation - https://www.ifa.org.au/lightforrileySharing Knowledge about immunisation - https://skai.org.au/healthcare-professionals/talking-parents-who-have-questionsMelbourne Vaccine education centre - https://mvec.mcri.edu.au/references/vaccine-confidence/ The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  7. Sep 14

    Beyond Tummy Pain: Managing Coeliac Disease in Kids

    In this episode, Dr Julia Rawlinson is once again joined by Dr Emma Turner, Paediatric Gastroenterologist and Hepatologist at Perth Children’s Hospital, and Dr Erin Horsley, GP Anaesthetist with a special interest in gastroenterology and lived experience parenting a child with coeliac disease. For the second part of their discussion on coeliac disease in children. Dr Emma outlines key aspects of long-term management following a coeliac disease diagnosis. She highlights the necessity of early dietitian involvement for gluten-free diet education and stresses the importance of annual monitoring, including coeliac serology, full blood count, liver function, iron studies, thyroid function, and vitamin D. Covering the risk of ongoing small bowel inflammation and malignancy associated with continued gluten exposure, even in children without acute symptoms, and provides practical tips on identifying hidden sources of gluten. Dr Erin shares her lived experience as a parent, emphasising family education, membership in Coeliac Australia, and engaging with schools and peer families for support. The unique challenges faced by adolescents with coeliac disease are also addressed, with a recommendation for ongoing dietetic input during periods of increasing independence. Links & Resources: https://coeliac.org.au/health-professionals/gluten-challenge/Health professionals - Coeliac AustraliaOngoing management - Coeliac Australiahttps://coeliac.org.au/health-professionals/ongoing-management/ The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

  8. Sep 7

    Beyond Tummy Pain: Coeliac Disease in Children

    In this episode, Dr Julia Rawlinson is joined in this two-part series by Dr Emma Turner, Paediatric Gastroenterologist and Hepatologist at Perth Children’s Hospital, and Dr Erin Horsley, GP Anaesthetist with a special interest in gastroenterology and lived experience parenting a child with coeliac disease. Providing practical advice for GPs on recognising and investigating coeliac disease in Australian children. Key points discussed: Prevalence and Risk: Coeliac disease affects about 1 in 70 Australians, with 80% undiagnosed. First-degree relatives have a 10-20% risk depending on family history.Clinical Presentation: Symptoms can include iron deficiency, growth failure, pubertal delay, abdominal pain, and altered bowel habits. Less obvious presentations might be behavioural issues, sleep problems, mild elevation of liver enzymes, dental enamel defects, and recurrent mouth ulcers. Diagnosis should still be considered in children who are growing normally or are obese.Testing Approach: The recommended initial tests are tissue transglutaminase IgA (TTG-IgA) and total IgA. Gluten intake must be adequate for accurate results. There is no current recommendation for population screening, but GPs are encouraged to maintain a low threshold for testing symptomatic children.Diagnosis and Specialist Involvement: Non-biopsy diagnosis can be considered for children with TTG-IgA >10× upper limit of normal plus confirmatory endomysial antibody testing, but all cases require confirmation by a paediatric gastroenterologist. Early gluten-free diets before testing complicate diagnosis and may require a supervised gluten challenge.Screening Relatives and Genetic Testing: All first-degree relatives should be screened, ideally at the time of index case diagnosis, and re-tested every 2–3 years if negative. HLA genetic testing is useful only to exclude coeliac disease, not to confirm it. Part 2 will focus on managing coeliac disease long term and practical advice for GPs and families. Links & Resources: https://coeliac.org.au/health-professionals/gluten-challenge/Health professionals - Coeliac AustraliaOngoing management - Coeliac Australiahttps://coeliac.org.au/health-professionals/ongoing-management/ The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network If you have any questions or would like to contact The Good GP, send an email to thegoodgp@gmail.com. Visit www.thegoodgp.com.au for previous episodes and more information. You can also find us on our Instagram page: @thegoodgppodcast. Follow us for more updates!

See All (292)

Ratings & Reviews

4.4
out of 5
9 Ratings

About

The Good GP, the education podcast for busy GPs; brought to you by Dr Tim Koh, Dr Krystyna DeLange and Dr Sean Stevens. The Good GP is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Disclaimer: The Good GP podcasts are for informational purposes only and do not constitute medical advice. Always seek the advice of a specialist GP or other qualified health provider with any questions you may have regarding a medical condition.

Information

  • Channel
    THT Productions
  • Creator
    The Good GP
  • Years Active
    2017 - 2026
  • Episodes
    292
  • Rating
    Clean
  • Copyright
    © Copyright 2026 The Good GP
  • Show Website
    The Good GP

More From THT Productions

You Might Also Like